Call Us Now

+91 9606900005 / 04

For Enquiry

legacyiasacademy@gmail.com

Malaria’s new frontlines

Malaria control in India has entered a decisive phase, powered by vaccine breakthroughs and innovation. Yet, persistent tribal hotspots and policy gaps challenge the 2030 elimination goal. Relevance : GS 2(Health , Governance) India’s Progress & Persistent Challenges Achievements: Persisting Hotspots:  Malaria Parasites in India First-Generation Vaccines 1. RTS,S (Mosquirix) 2. R21/Matrix-M (Oxford–Serum Institute) Limitations of […]

AfaDixVax: India’s New Weapon Against Malaria

Malaria Burden and New Hope Relevance : GS 2(Health , Governance ) Declining Trend in India (1995–2022) What is AfaDixVax and Why it Matters Adjuvant & Safety Advantage Production, IP, and Commercial Path Global Context & India’s Role

Vitamin D deficiency linked to neuro developmental issues

From Bones to Brains: Expanding the Role of Vitamin D Relevance : GS 2(Health ) Key Findings from the Danish Study Biological Mechanism and Genetic Insights Indian Context: Sunlight-Rich, Yet Vitamin D–Poor Pregnancy and the Biological Inheritance of Deficiency Clinical Practice in India: Slow But Emerging Response Policy & Public Health Implications Balanced Perspective

ICMR Pushes Diagnostics Decentralisation Across States

Strengthening Health Federalism through Decentralised Diagnostics Relevance : GS 2(Health , Social Issues , Governance) Advancing the Right to Health (Article 21) Directive Principles in Action Science-Led Policy via Public Institutions Centre-State Executive Coordination Governance Reform & Local Accountability Reducing the Urban–Rural Health Divide

The end of tuberculosis that wasn’t

Background Context Relevance : GS 2(Health , Governance , Social Issues) Three Main Drivers of TB Resurgence in Developed Countries HIV/AIDS Epidemic Drug-Resistant TB (DR-TB) Migration & Global Movement Global Wake-Up Call Data-Driven Policy Shifts  Impact Since 2000 Relevance for India Policy Takeaways Tuberculosis (TB)

Chemotherapy drugs made by Indian firms fail quality tests

Key Findings from the Study Relevance : GS 2(Health , Governance ) Drugs & Manufacturers Under Scrutiny   Types of Drug Failures Global Regulatory Gaps India: Major Supplier, Questionable Oversight High Stakes for Patients Larger Implications